Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders

被引:0
|
作者
Ann Woolfrey
Tao Wang
Stephanie J. Lee
Michael D. Haagenson
Ge Chen
Katharina Fleischhauer
John Horan
Katharine Hsu
Michael Verneris
Stephen R. Spellman
Marcelo Fernandez-Vina
机构
[1] Fred Hutchinson Cancer Research Center,Center for International Blood and Marrow Transplant Research
[2] Medical College of Wisconsin,Institute for Experimental Cellular Therapy
[3] Center for International Blood and Marrow Transplant Research,undefined
[4] Stanford School of Medicine,undefined
[5] University Hospital Essen,undefined
[6] Emory University,undefined
[7] Memorial Sloan Kettering Cancer Center,undefined
[8] University of Colorado-Children’s Hospital,undefined
来源
关键词
Donor-specific antibodies; unrelated donors; hematopoietic cell transplantation, graft rejection; survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:494 / 496
页数:2
相关论文
共 50 条
  • [31] No impact of donor non-specific anti-HLA antibodies on engraftment in unrelated cord blood transplantation in adult
    Yamamoto, H.
    Kaihori, I.
    Matsuno, N.
    Ota, H.
    Taya, Y.
    Nishida, A.
    Ikebe, T.
    Ishiwata, K.
    Tsuji, M.
    Narita, M.
    Tsuchihashi, R.
    Asano-Mori, Y.
    Uchida, N.
    Izutsu, K.
    Wake, A.
    Yoneyama, A.
    Makino, S.
    Taniguchi, S.
    [J]. BONE MARROW TRANSPLANTATION, 2012, 47 : S279 - S280
  • [32] Donor-Specific HLA Antibodies Are Associated with Graft Failure and Delayed Hematologic Recovery after Unrelated Donor Hematopoietic Cell Transplantation
    Martins Lima, Alberto Cardoso
    Getz, Joselito
    do Amaral, Geovana Borsato
    Loth, Gisele
    Moreira Funke, Vaneuza Araujo
    Nabhan, Samir Kanaan
    Petterle, Ricardo Rasmussen
    de Marco, Renato
    Gerbase-DeLima, Maria
    Pereira, Noemi Farah
    Bon, Carmem
    Pasquini, Ricardo
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (08): : 493.e1 - 493.e10
  • [33] Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience
    Ius, F.
    Sommer, W.
    Rojas, S. V.
    Kaufeld, T.
    Bara, C.
    Salman, J.
    Poyanmehr, R.
    Avsar, M.
    Tudorache, I.
    Falk, C. S.
    Haverich, A.
    Warnecke, G.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S241 - S241
  • [34] Prevalence and Impact of Reformed and De Novo Anti-HLA Donor-Specific Antibodies in Liver Transplantation
    Papachristou, M.
    Fylaktou, A.
    Daoudaki, M.
    Cholongitas, E.
    Karampatakis, T.
    Anastasiou, A.
    Chatzika, G.
    Makrovasili, F.
    Vagiotas, L.
    Karakasi, K.
    Fouzas, I.
    [J]. TRANSPLANTATION PROCEEDINGS, 2019, 51 (02) : 424 - 428
  • [35] Clinically-relevant threshold of preformed donor-specific anti-HLA antibodies in kidney transplantation
    Salvade, Igor
    Aubert, Vincent
    Venetz, Jean-Pierre
    Golshayan, Dela
    Saouli, Anne-Catherine
    Matter, Maurice
    Rotman, Samuel
    Pantaleo, Giuseppe
    Pascual, Manuel
    [J]. HUMAN IMMUNOLOGY, 2016, 77 (06) : 483 - 489
  • [36] REASSESSMENT OF THE CLINICAL IMPACT OF PREFORMED DONOR-SPECIFIC ANTI-HLA CW ANTIBODIES IN KIDNEY TRANSPLANTATION
    Visentin, J.
    Bachelet, T.
    Aubert, O.
    Del Bello, A.
    Martinez, C.
    Jambon, F.
    Guidicelli, G.
    Ralazamahaleo, M.
    Bouthemy, C.
    Cargou, M.
    Congy-Jolivet, N.
    Nong, T.
    Lee, J. H.
    Sberro-Soussan, R.
    Couzi, L.
    Kamar, N.
    Legendre, C.
    Merville, P.
    Taupin, J. L.
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 6 - 6
  • [37] Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation
    Cutler, Corey
    Kim, Haesook T.
    Sun, Lixian
    Sese, Doreen
    Glotzbecker, Brett
    Armand, Philippe
    Koreth, John
    Ho, Vincent
    Alyea, Edwin
    Ballen, Karen
    Ritz, Jerome
    Soiffer, Robert J.
    Milford, Edgar
    Antin, Joseph H.
    [J]. BLOOD, 2011, 118 (25) : 6691 - 6697
  • [38] Treatment of Anti-HLA Donor-Specific Antibodies in Heart Transplantation: A Single-Center Experience
    Salman, J.
    Kaufeld, T.
    Aburahma, K.
    Bara, C.
    Niehaus, A.
    Poyanmehr, R.
    Avsar, M.
    Falk, C. S.
    Sommer, W.
    Haverich, A.
    Warnecke, G.
    Lus, F.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2021, 40 (04): : S294 - S294
  • [39] WHICH PREFORMED DONOR-SPECIFIC ANTI-HLA ANTIBODIES ARE CLINICALLY RELEVANT?
    Salvade, Igor
    Aubert, Vincent
    Venetz, J. P.
    Golshayan, Dela
    Sugamele, Rocco
    Gregoretti, Stephanie
    Pantaleo, Giuseppe
    Pascual, Manuel
    [J]. TRANSPLANT INTERNATIONAL, 2015, 28 : 70 - 71
  • [40] CLINICAL SIGNIFICANCE OF DE NOVO DONOR-SPECIFIC ANTI-HLA ANTIBODIES AFTER KIDNEY TRANSPLANTATION
    Jung, Hee-Yeon
    Kim, Ryang Hi
    Park, Sang Mi
    Park, Jung Hwa
    Lee, Kyung Hee
    Lee, Eun Song
    Lim, Jeong-Hoon
    Kim, Kyu Yeun
    Choi, Ji-Young
    Cho, Jang-Hee
    Park, Sun-Hee
    Kim, Yong-Lim
    Kim, Chan-Duck
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 245 - 245